USFDA green lights Sandoz’s biosimilar Tyruko to treat multiple sclerosis Â
HQ Team August 25, 2023: The US drug regulator gave its nod for Sandoz Inc., an arm of Sweden-based Novartis and which is.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team August 25, 2023: The US drug regulator gave its nod for Sandoz Inc., an arm of Sweden-based Novartis and which is.
HQ Team August 9, 2023: The brain’s hypothalamus gland is a relevant factor in obesity and little is known about how this region.
A magic drug approved for asthma by the US FDA can restore lost memories and reveal previously hidden knowledge, say Netherland scientists
he current treatment of cortical malformations in the anterior parts of the brain, or cerebrum, in vertebrates by its surgical removal to cure.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com